Collaborative medicine

BMS' Commitment to Precision Medicine for Patients Living With Immune-Mediated Diseases


Kellie Calderon, MD, executive medical director at Bristol Myers Squibb, has built her career in both clinical practice as well as in the pharmaceutical industry. Through her experiences, she has learned the value of collaboration and the importance of precision medicine — both of which are vital in advancing treatments and care for people living with immune-mediated diseases.

What excites you about the work that Bristol Myers Squibb is doing in immunology? And more specifically, rheumatology?

Subscribe to Collaborative medicine